Who is sponsoring NCT07581132?

NCT07581132 is sponsored by Akdeniz University.

What drugs are being tested in NCT07581132?

Interventions in NCT07581132: Structured Energy Conservation Techniques Training.

What condition does NCT07581132 study?

NCT07581132 studies Chronic Obstructive Pulmonary Disease (COPD).

Is NCT07581132 still recruiting?

NCT07581132 is currently not yet recruiting.

Last reviewed 2026-06-09 · How we verify

NCT07581132

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients

Not yet recruiting NA

What this trial tests

NA trial testing Structured Energy Conservation Techniques Training in Chronic Obstructive Pulmonary Disease (COPD) in 70 participants. Not yet recruiting.

Timeline

10 July 2026

10 January 2027

Quick facts

Lead sponsor	Akdeniz University
Phase	NA
Status	Not yet recruiting
Enrollment	70
Start date	10 July 2026
Estimated completion	10 January 2027

Drugs / interventions tested

Structured Energy Conservation Techniques Training

Conditions studied

Chronic Obstructive Pulmonary Disease (COPD) — all drugs for Chronic Obstructive Pulmonary Disease (COPD) →

Sponsor

Akdeniz University

Who can join

Eligibility, any sex, with Chronic Obstructive Pulmonary Disease (COPD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Obstructive Pulmonary Disease (COPD)

Currently open trials in the same condition.

NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
NCT07355868 — Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy · EARLY_PHASE1 · recruiting
NCT06892210 — Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) · Phase 4 · recruiting
NCT07477600 — cfMSC Stem Cell Therapy Targeting COPD · Phase 1, PHASE2 · recruiting
NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting

Other Akdeniz University trials

Trials by the same sponsor.

NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
NCT07507279 — Technology-based Hand Rehabilitation in Older People · NA · not yet recruiting
NCT07437924 — Bruxism and Pelvic Floor Dysfunction in Young Women · enrolling by invitation
NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting
NCT07253571 — The Effect of Artificial Intelligence-Supported Intramuscular and Subcutaneous Injection Training on Nursing Students · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07581132 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
Last refreshed: recently

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07581132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing